HHS Will Likely Face More Lawsuits Against Drug Price Negotiation Now That It Has Named The First 10 Meds Included In The Plan

Novartis became the seventh drugmaker to legally challenge the White House’s Medicare drug pricing negotiation program.
The post HHS Will Likely Face More Lawsuits Against Drug Price Negotiation Now That It Has Named The First 10 Meds Included In The Plan appeared first on Above the Law.
Responses